Adult Hypersensitivity (HSR)/Allergic Reaction Management
|
|
- Jonathan Wilkerson
- 6 years ago
- Views:
Transcription
1 Page 1 of 5 Patient with HSR to medication (For blood product related HSR see Page 2) PRESENTING SYMPTOMS Fever 1, chills, and/or rigors Acetaminophen within 4 hours or Stem Cell Transplant patient? Call the Attending or On-Call Physician for additional instructions Give Acetaminophen 1,000 mg PO for 1 dose per order set STOP Infusion and monitor vital signs every 5 minutes Call the On-Call Physician STAT and notify the Attending Physician Itching, facial flushing hives (urticaria), rash Hypotension 2, wheezing, shortness of breath, facial/lip/ tongue swelling Other signs or symptoms of HSR/ allergic reaction Give Diphenhydramine 50 mg IV push over 2 minutes Place pulse oximeter. Start O 2 at 2 liters/minute by nasal cannula if saturation less than or equal to 92%. Start rmal saline at 150 ml/hour Call the On-Call Physician for instructions 1 Fever defined as greater than 38.3 C or greater than or equal to 38 C for 1 hour or longer 2 Hypotension defined as a systolic blood pressure (SBP) less than 90 mmhg or a drop in SBP of more than 20 mmhg from baseline 3 HSR/Allergy Kit includes the following (all in tamper-evident bag): Epinephrine 1:1,000 vial Tuberculin syringe (1 ml) with needle Diphenhydramine 50 mg vial Tuberculin syringe (1 ml) with needle Hydrocortisone 100 mg vial 3 ml syringe and 20 G, 1 inch needle Improvement within 5 minutes? Hydrocortisone 100 mg IV push over 1 minute and repeat Diphenhydramine 50 mg IV push over 2 minutes Epinephrine 1:1, ml subcutaneously, followed by Diphenhydramine 50 mg IV push over 2 minutes (if not administered within last 30 minutes), followed by Hydrocortisone 100 mg IV push over 1 minute te: Utilize HSR/Allergy Kit 3 in Pyxis and order set Evaluation and disposition by On-Call physician; re-evaluate need for IVF Additional orders per On-Call Physician Documentation 1) Use HSR/Allergy Order Set to document management utilized for an individual patient. 2) Enter as Observed Adverse Drug Reaction (ADR) in Nursing Documentation in OneConnect.
2 Patient with HSR to blood product transfusion PRESENTING SYMPTOMS Fever 1, chills, and/or rigors Itching, facial flushing, hives (urticaria), rash Hypotension 2, wheezing, respiratory distress 3, facial/lip/tongue swelling Other signs or symptoms 4 of HSR/ allergic reaction Management of Blood Product Transfusion Reaction-ADULT STOP blood product transfusion and monitor vital signs every 5 minutes Call the On-Call Physician for instructions Give diphenhydramine 25 mg IV push over 2 minutes Continue transfusion Monitor vital signs every 5 minutes STOP blood product transfusion and monitor vital signs every 5 minutes Call the On-Call Physician for instructions Place pulse oximeter Start O 2 at 2 liters/minute by nasal cannula if saturation less than or equal to 92% Start rmal saline at 150 ml/hour STOP blood product transfusion and monitor vital signs every 5 minutes Call the On-Call Physician for instructions Improvement within 15 minutes? STOP blood product transfusion and monitor vital signs every 5 minutes Hydrocortisone 100 mg IV push over 1 minute and repeat Diphenhydramine 50 mg IV push over 2 minutes Epinephrine 1:1, ml subcutaneously, followed by Diphenhydramine 50 mg IV push over 2 minutes (if not administered within last 30 minutes), followed by Hydrocortisone 100 mg IV push over 1 minute te: Utilize HSR/Allergy Kit in Pyxis and Order Set or SmartSet HSR/Allergy Kit includes the following (all in tamper-evident bag): Epinephrine 1:1,000 vial Tuberculin syringe (1mL) with needle Diphenhydramine 50 mg vial Tuberculin syringe (1mL) with needle Hydrocortisone 100 mg vial 3 ml syringe and 20 G, 1 inch needle Evaluation and disposition by On-Call Physician; re-evaluate need for IVF Page 2 of 5 1 Fever defined as greater than 38.3 C or greater than or equal to 38 C for 1 hour or longer 2 Hypotension defined as a systolic blood pressure (SBP) less than 90 mmhg or a drop in SBP of more than 20 mmhg from baseline Adult Hypersensitivity (HSR)/Allergic Reaction Management Additional orders per On-Call Physician See Page 3 for Transfusion Reaction Work-up and Reporting 3 Respiratory distress may include, but is not limited to: shortness of breath, hypoxia, dyspnea or labored respiration, wheezing, orthopnea, stridor 4 Other signs and symptoms may include, but are not limited to: Chest pain, tachycardia, tachypnea, hypertension Low back pain and/or flank pain Headache occurring during transfusion Discoloration of urine (tea, cola, or blood colored urine)
3 Page 3 of 5 Management of Blood Product Transfusion Reaction-ADULT TRANSFUSION REACTION WORK-UP AND REPORTING Laboratory tests: Anti-IgA antibodies Urinalysis for presence of hemoglobin Other appropriate laboratory tests Reporting: Place a Transfusion Medicine consult Complete a Patient Safety Event report Complete a Transfusion Reaction Investigation request Return the remaining blood tubing to Blood Bank
4 Page 4 of 5 SUGGESTED READINGS Al-Riyami, A. Z., Al-Hashmi, S., Al-Arimi, Z., Wadsworth, L. D., Al-Rawas, A., Al-Khabori, M., & Daar, S. (2014). Recognition, investigation and management of acute transfusion reactions: consensus guidelines for Oman. Sultan Qaboos University medical journal, 14(3), e306. Gomes E.R. & Demoly P. (2005). Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol, 5, Lenz, H. J. (2007). Management and preparedness for infusion and hypersensitivity reactions. The Oncologist, 12(5), Lieberman, P., Kemp, S. F., Oppenheimer, J., Lang, D. M., Bernstein, I. L., Nicklas, R. A.,... & Greenberger, P. A. (2005). The diagnosis and management of anaphylaxis: an updated practice parameter. Journal of Allergy and Clinical Immunology, 115(3), S483-S523. Link, M. S., Berkow, L. C., Kudenchuk, P. J., Halperin, H. R., Hess, E. P., Moitra, V. K.,... & White, R. D. (2015). Part 7: Adult Advanced Cardiovascular Life Support 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation, 132 (18 suppl 2), S444-S464. National Guideline Clearinghouse (NGC) Guideline summary: Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Accessed October 31, 2017 Rushton, F.A. (2007). Recognition and management of patients with anaphylaxis. Nursing Standards, (21), 37, UTMDACC Institutional Policy #CLN1115 Blood Component Administration and Transfusion Reaction Policy Zanotti K.M. & Markman, M. (2001). Prevention and management of antineoplastic induced hypersensitivity reactions. Drug Safety, 24,
5 Page 5 of 5 DEVELOPMENT CREDITS This practice consensus algorithm is based on majority expert opinion of the Adult Hypersensitivity Reaction work group at the University of Texas MD Anderson Cancer Center. It was developed using a multidisciplinary approach that included input from the following experts: Amin Alousi, MD (Stem Cell Transplantation) Carmen Escalante, MD (General Internal Medicine) Olga N. Fleckenstein Firoze Jameel, MSN, RN, OCN Huifang Linda Lu, MD, PhD (General Internal Medicine) Wenli Liu, MD (Integrative Medicine Program) Ellen Manzullo, MD (General Internal Medicine) Laura Michaud, PhD, PharmD, RPh (Pharmacy Clinical Programs) Rina Patel, PharmD, RPh (Pharmacy Clinical Programs) Goley Richardson, BSN, RN, OCN (Nursing Administration) Leonard Roes, PharmD, RPh (Pharmacy Inpatient) Gloria Trowbridge, MSN, RN Clinical Effectiveness Development Team
Transfusion Reactions
Transfusion Reactions From A to T Provincial Blood Coordinating Program Daphne Osborne MN PANC (C) RN We want you to know Definition Appropriate actions Classification Complete case studies Transfusion
More informationHome Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE
UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: 253.054 First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating
More informationBlood/Blood Component Utilization and Administration Annual Compliance Education
Blood/Blood Component Utilization and Administration Annual Compliance Education This course contains annual compliance education necessary to meet compliance and regulatory requirements. Instructions:
More informationWest Penn Allegheny Health System Forbes Regional Hospital
Policy Name: Treatment of Anaphylactic Reaction In the Cath Lab Original Date: West Penn Allegheny Health System Forbes Regional Hospital Policy No. 16553 Page 1 of 6 Reviewed by : Mark Taylor, MD, Michael
More informationTRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER?
TRANSFUSION SAFETY 101 ARE YOU SMARTER THAN A BLOOD BANKER? 1. Fatal blood transfusion reactions are most likely the result of: a. Circulatory overload b. ABO incompatible blood due to patient identification
More informationRITUXIMAB RHEUMATOLOGY VASCULITIS
. PHYSICIAN (Patient Sticker) ORDER SET : CDH 208-237 Approved - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility Name:
More informationAllergic Reactions and Envenomations. Chapter 16
Allergic Reactions and Envenomations Chapter 16 Allergic Reactions Allergic reaction Exaggerated immune response to any substance Histamines and leukotrienes Chemicals released by the immune system Anaphylaxis
More informationTo provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML).
PURPOSE To provide guidelines for the identification, management and reporting of a suspected transfusion reaction to Transfusion Medicine Laboratory (TML). SITE APPLICABILITY BC Children s Hospital and
More informationMB Guideline 7. Transfusion Reaction- Identification, Management and Reporting
MB Guideline 7 Transfusion Reaction- Identification, Management and Reporting When any unexpected or untoward sign or symptom occurs during or shortly after the transfusion of a blood component, a transfusion
More informationHave you ever managed patients who have experienced an adverse reaction to transfusion?
Have you ever managed patients who have experienced an adverse reaction to transfusion? A. Yes, often B. Yes, occasionally C. No A. 1 in 30 units? B. 1 in 100? C. 1 in 1000? D. 1 in 10,000? SHOT collects
More informationTREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE
TREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE FILE: JGCDC Background: The Bibb County School System recognizes the growing concern with severe life-threatening allergic reactions to food items, latex,
More informationPHYSICIAN ORDER SET : Patient: DOB: Gender: Patient Phone #: Height: Weight:
. (Patient Sticker) CDH 208-203 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility Name: Ordering Provider:
More informationApproach to a patient with suspected blood transfusion reaction. Raju Vaddepally, MD
Approach to a patient with suspected blood transfusion reaction Raju Vaddepally, MD Goals Detection of Acute Transfusion Reactions (ATR) Clinical and Laboratory Evaluation of ATR Management of individual
More informationPRIMARY CARE PRACTICE GUIDELINES
Community Mgmt Team - 1 of 6 1. OUTCOME To identify anaphylaxis in the primary care setting and provide an evidence informed emergency response utilizing the most current provincial and federal practice
More informationPrimary Care practice clinics within the Edmonton Southside Primary Care Network.
Allergy/Immunotherapy Injections Last Review: November 2016 Intervention(s) and/or Procedure: Administration of allergen injections throughout immunotherapy treatment. Immunotherapy for allergic disease
More informationAllergy Immunotherapy in the Primary Care Setting
Allergy Immunotherapy in the Primary Care Setting New York State College Health Association 2008 COMBINED ANNUAL MEETING October 2008 Mary Madsen RN BC University of Rochester Issues in Primary Care Practice
More informationDrew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax:
Dear Student, Enclosed you will find our policies, procedures and student consent form for your allergy immunotherapy. We ask that you read them carefully, sign the consent form, and take the physician
More informationTRANSFUSION OF BLOOD COMPONENTS ADMINISTRATION. All blood components are administered according to BOP DHB Policy and NZBS Guidelines.
STANDARDS All blood components are administered according to BOP DHB Policy and NZBS Guidelines. EQUIPMENT IV administration set with 260 micron filter either integrated blood filter; or add on blood filter
More informationBoot Camp Transfusion Reactions
Boot Camp Transfusion Reactions Dr. Kristine Roland Regional Medical Lead for Transfusion Medicine, VCH Objectives By the end of this session, you should be able to: Describe in common language the potential
More informationUnit 5: Blood Transfusion
Unit 5: Blood Transfusion Blood transfusion (BT) therapy: Involves transfusing whole blood or blood components (specific portion or fraction of blood lacking in patient). Learn the concepts behind blood
More informationTitle: Management of Allergic Reactions after IV Contrast in Magnetic Resonance Imaging
ABSTRACT FOR SPS POSTER CASE PRESENTATION K Singer Title: Management of Allergic Reactions after IV Contrast in Magnetic Resonance Imaging Introduction: Children undergoing radiologic imaging frequently
More informationINFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE WEEKS 0, 2, 6)
. INFLIXIMAB RHEUMATOLOGY LOAD DOSE (SCHEDULE CDH 208-211 Approved 2/18 - Page 1 of 5 Patient: DOB: Gender: Patient Phone #: Height: Weight: Diagnosis: ICD-10 Code: Treatment Start Date: Provider Facility
More informationPrimary Care practice clinics within the Edmonton Southside Primary Care Network.
Administration of Immunizations Last Review: November 2016 Intervention(s) and/or Procedure: Practice Setting: Authorized Implementers: Competencies and Educational Requirements: Administration of immunizations
More informationBRAJACTT. Protocol Code. Breast. Tumour Group. Dr. Karen Gelmon. Contact Physician
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer using DOXOrubicin and Cyclophosphamide followed by PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group Contact Physician
More informationComponents of Blood. N26 Blood Administration 4/24/2012. Cabrillo College ADN/C. Madsen RN, MSN 1. Formed elements Cells. Plasma. What can we give?
Components of Blood Formed elements Cells Erythrocytes (RBCs) Leukocytes (WBCs) Thrombocytes (platelets) Plasma 90% water 10% solutes Proteins, clotting factors 1 What can we give? Whole blood Packed RBC
More informationEpinephrine Intramuscular (IM) Injection Administration EMT Optional Scope Highlights
Epinephrine Intramuscular (IM) Injection Administration EMT Optional Scope Highlights Nor-Cal EMS February 2018 version 1 Special Thank You To Seattle / King County EMS NY State Department of Health, Check
More informationStudent Health Center
Referring Allergist Agreement Your patient is requesting that the University of Mary Washington Student Health Center (UMWSHC) administer allergy extracts provided by your office. Consistent with our policies
More informationPolicy for the Treatment of Anaphylaxis in Adults and Children
Policy for the Treatment of Anaphylaxis in Adults and Children June 2008 Policy Title: Policy for the Treatment of Anaphylaxis in Adults or Children Policy Reference Number: PrimCare08/17 Implementation
More informationREPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS
REPORT OF TRANSFUSION ADVERSE REACTION TO BLOOD CENTERS INSTRUCTIONS: Send the form to ALL blood centers that provided blood components to this patient. Timely reporting is important, so that, if appropriate,
More informationEmergency Department Guideline. Anaphylaxis
Emergency Department Guideline Inclusion criteria: 1. Acute onset of an illness (minutes to hours) with a AND (b OR c): a. Skin and/or mucosa (pruritus, flushing, hives, angioedema) b. Respiratory compromise
More informationBRAVTPCARB. Protocol Code: Breast. Tumour Group: Dr. Karen Gelmon. Contact Physician:
BCCA Protocol Summary for Palliative Therapy for Metastatic Breast Cancer using Trastuzumab (HERCEPTIN), PACLitaxel and CARBOplatin as First-Line Treatment for Advanced Breast Cancer Protocol Code: Tumour
More informationTerms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations. Anaphylaxis; LBodak
Leslie Bodak, EMT-P Terms What is Anaphylaxis? Causes Signs & Symptoms Management Education Pictures Citations Allergic Reaction: an abnormal immune response the body develops when a person has been previously
More information2/2/2011. Blood Components and Transfusions. Why Blood Transfusion?
Blood Components and Transfusions Describe blood components Identify nursing responsibilities r/t blood transfusion Discuss factors r/t blood transfusion including blood typing, Rh factor, and cross matching
More informationCycle 1 PERTuzumab (day 1) and trastuzumab (day 2) loading doses: Drug Dose BC Cancer Administration Guideline
BC Cancer Protocol Summary for Palliative Therapy for Metastatic Breast Cancer Using PERTuzumab, Trastuzumab (HERCEPTIN), and PACLItaxel as First-Line Treatment for Advanced Breast Cancer Protocol Code:
More informationChapter 26. Assisting With Oxygen Needs. Elsevier items and derived items 2014, 2010 by Mosby, an imprint of Elsevier Inc. All rights reserved.
Chapter 26 Assisting With Oxygen Needs Oxygen (O 2 ) is a gas. Oxygen Ø It has no taste, odor, or color. Ø It is a basic need required for life. Death occurs within minutes if breathing stops. Brain damage
More informationFLUID MANAGEMENT AND BLOOD COMPONENT THERAPY
Manual: Section: Protocol #: Approval Date: Effective Date: Revision Due Date: 10/2019 LifeLine Patient Care Protocols Adult/Pediatrics AP1-011 10/2018 10/2018 FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY
More informationVACCINE-RELATED ALLERGIC REACTIONS
VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis Public Health Immunization Program June 2018 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever,
More informationSTEP-BY-STEP GUIDE TO SELF-INFUSION. Subcutaneous Administration of GAMMAGARD LIQUID
STEP-BY-STEP GUIDE TO SELF-INFUSION Subcutaneous Administration of GAMMAGARD LIQUID This handy guide will help you manage your subcutaneous administration of GAMMAGARD LIQUID. If you have questions on
More informationIntroduction to Emergency Medical Care 1
Introduction to Emergency Medical Care 1 OBJECTIVES 22.1 Define key terms introduced in this chapter. Slides 10, 14, 19, 37, 39 22.2 Differentiate between the signs and symptoms of an allergic reaction
More informationBC Cancer Protocol for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel
BC Cancer Protocol for Treatment of Platinum Resistant Epithelial Ovarian Cancer with Bevacizumab and PACLitaxel Protocol Code Tumour Group Contact Physician UGOOVBEVP Gynecologic Oncology Dr. Anna Tinker
More informationAnaphylaxis: Treatment in the Community
: Treatment in the Community is likely if a patient who, within minutes of exposure to a trigger (allergen), develops a sudden illness with rapidly progressing skin changes and life-threatening airway
More informationAnaphylaxis: treatment in the community
: treatment in the community Item Type Guideline Authors Health Service Executive Citation Health Service Executive. : treatment in the community. Dublin: Health Service Executive;. 5p. Publisher Health
More informationBC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab (HERCEPTIN)
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Weekly PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code: Tumour Group: Contact Physician: UBRAJTTW Breast Dr. Angela Chan ELIGIBILITY:
More informationManagement of an immediate adverse event following immunisation
Management of an immediate adverse event following immunisation The vaccinated person should remain under observation for a short interval to ensure that they do not experience an immediate adverse event.
More informationCHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL
CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL Item Changed Airway Management Procedure Oral Intubation Procedure Tube Confirmation and Monitoring Procedure C10 Chest Pain/ACS M2 Allergic Reaction/Anaphylaxis
More informationBC Cancer Protocol Summary for Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
BC Cancer Protocol Summary for Combined Cetuximab and Radiation Treatment for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Protocol Code Tumour Group Contact Physician HNLACETRT Head and
More informationVACCINE-RELATED ALLERGIC REACTIONS
VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis IERHA Immunization Program September 2016 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever, lymphadenopathy
More informationD-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin
Package leaflet: Information for the patient D-Gam 50 micrograms/ml D-Gam 250 micrograms/ml Solution for injection human anti-d immunoglobulin Read all of this leaflet carefully before you start using
More information*Monitor for significant side effects, especially symptoms of neurological or cardiovascular events.
Assessment Prior to administration: Obtain complete health history including allergies, drug history, and possible drug reactions Assess reason for drug administration such as presence/history of anemia
More informationAnaphylaxis. Ria Dindial. Photo courtesy: nhs.co.uk
Anaphylaxis Ria Dindial Photo courtesy: nhs.co.uk Question 1 A PGY-1 resident is about to present some information on Anaphylaxis. You have read this several times in Medical school and feel confident
More informationINVESTIGATION OF ADVERSE TRANSFUSION REACTIONS TABLE OF RECOMMENDED TESTS. Type of Reaction Presentation Recommended Tests Follow-up Tests
Minor Allergic (Urticarial) Urticaria, pruritis, flushing, rash If skin reaction only and mild hives/ rash
More informationOBSERVATION UNIT ASTHMA PATHWAY OUTLINE Westmoreland Hospital PAGE 1 OF 5
PAGE 1 OF 5 Exclusion Criteria: (Reason to admit to hospital) A. New EKG changes except sinus tachycardia B. Respiratory Rate > 40 C. Signs/symptoms of Heart Failure D. Impending respiratory failure or
More informationALL orders are active unless: 1. Order is manually lined through to inactivate 2. Orders with check boxes ( ) are unchecked DRUG AND TREATMENT ORDERS
Available at: ALL Adult Facilities Non Categorized SUB Protocol(SUB)* SUB Protocol Lab Orders(SUB)* ED Rainbow Tubes(SUB)* ***Reminder: Order ED Rainbow Tubes (SUB) as a separate form*** Nursing Orders
More informationNURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet)
NURSING PROCESS FOCUS: Patients Receiving Amphotericin B (Fungizone, Abelcet) ASSESSMENT Prior to administration: Obtain complete health history including allergies, drug history, and possible drug interactions.
More informationAbatacept (Orencia ) How does it work? Why take it? How quickly does it work? How do I take it?
Abatacept (Orencia ) How does it work? Abatacept is a biologic medicine that helps keep the imune system from attacking healthy tissues in the body by blocking the T cells from being turned on. Abatacept
More informationMedical First Responder Program Protocols
Medical Scene Safety Protocol Verify Scene Safety with Police or Dispatch UNKWN Scene Safe? Enter Continue to Appropriate Protocol Possible to Make Safe Make Safe Then Continue Exit Area and Stage Outside
More informationULYRICE. Protocol Code. Lymphoma. Tumour Group. Dr. Laurie Sehn. Contact Physician
BCCA Protocol Summary for the Treatment of Relapsed or Refractory Advanced Stage Aggressive B-Cell Non-Hodgkin s Lymphoma with Ifosfamide, CARBOplatin, Etoposide and rituximab Protocol Code Tumour Group
More informationChapter 8. Learning Objectives. Learning Objectives 9/11/2012. Anaphylaxis. List symptoms of anaphylactic shock
Chapter 8 Anaphylaxis Learning Objectives List symptoms of anaphylactic shock Discuss role of immune system in fighting antigens Define allergic response Learning Objectives Describe body s response to
More informationIn The Name Of GOD ADVERSE REACTIONS OF TRANSFUSION
In The Name Of GOD The 7 th international and 12 th national congress on quality improvement in clinical laboratories ADVERSE REACTIONS OF TRANSFUSION By Mehdi Allahbakhshian, PhD, Hematology and Blood
More informationRecognize Anaphylaxis Symptoms
Recognize Anaphylaxis Symptoms File: JHCD-F1 Recognize the Common Anaphylaxis Symptoms Sudden difficulty breathing, wheezing Hives, generalized flushing, itching, or redness of the skin, Swelling of the
More informationBRAJACTTG. Protocol Code. Breast. Tumour Group. Dr. Karen Gelmon. Contact Physician
BC Cancer Protocol Summary for Adjuvant Therapy for Breast Cancer Using Dose Dense Therapy: DOXOrubicin and Cyclophosphamide Followed by PACLitaxel and Trastuzumab (HERCEPTIN) Protocol Code Tumour Group
More informationTransfusion Reactions. Directed by M-azad March 2012
Transfusion Reactions Directed by M-azad March 2012 Transfusion Reactions are Adverse reactions associated with the transfusion of blood and its components Transfusion reactions Non-threatening to fatal
More informationAnti-Tumor Necrosis Factor (Anti-TNF)
Anti-Tumor Necrosis Factor (Anti-TNF) 110465 Anti-TNF.indd 1 9/20/16 9:01 AM s About your medicine Anti-tumor necrosis factor (anti-tnf) is a type of medicine called biologic agent that targets substance
More informationPROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY
MULTIDISCIPLINARY PROCEDURE PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY First Issued June 2011 Issue Version Four Purpose of Issue/Description of Change Planned Review Date To promote safe and consistent
More informationDefinitions of Current SHOT Categories & What to Report
Definitions of Current SHOT Categories & What to Report Revised March 2011 1 ADVERSE EVENTS TERM DEFINITION WHAT TO REPORT IBCT - Wrong Blood Transfused (Incorrect Blood Component Transfused) Where a patient
More informationANAPHYLAXIS Following Vaccination. A Severe Adverse Event. Developed for the Grampians Infection Control Group (GRICG) Version 2.
ANAPHYLAXIS Following Vaccination A Severe Adverse Event Developed for the Grampians Infection Control Group () Version 2.0:2014 Adverse Event Following Immunisation Adverse event following immunisation
More informationPICU ADMIT DKA PLAN - Phase: Begin Immediately
- Phase: Begin Immediately Diagnosis Weight Allergies Admit/Discharge/Transfer Patient Status Requested Location: PICU, Pt Status: Inpatient (LOS > 2 midnights) Requested Location: PICU, Pt Status: Observation
More informationEMT. Chapter 10 Review
EMT Chapter 10 Review 1. The term shock is MOST accurately defined as: A. a decreased supply of oxygen to the brain. B. cardiovascular collapse leading to inadequate perfusion. C. decreased circulation
More informationOlive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute
Adverse Events associated with Cell Therapy Products Olive J Sturtevant, MHP, MT(ASCP)SBB/SLS, CQA Director, Cellular Therapy Quality Assurance Dana Farber Cancer Institute 2 Objectives Review the types
More informationSystemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline
This is an official Northern Trust policy and should not be edited in any way Systemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline Reference Number: NHSCT/12/518 Target audience: This document
More informationPHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG
DRUG AND TREATMENT Available ONLY at: BMC-B BMC-D BMC-N BMC-S Nursing Orders Communication Order If CVP unavailable, administer fluid boluses every 30 minutes except monitor O2 requirements Comments: Every
More informationImmunocompetence The immune system responds appropriately to a foreign stimulus
Functions of the immune system Protect the body s internal environment against invading organisms Maintain homeostasis by removing damaged cells from the circulation Serve as a surveillance network for
More informationChemotherapy must not be started unless the following drugs have been given:
BC Cancer Protocol Summary for Second-Line Therapy for Metastatic or Locally Advanced Gastric or Gastroesophageal Junction Cancer Using Weekly PACLitaxel and Ramucirumab Protocol Code: Tumour Group: Contact
More informationWho Should Be Premediciated for Contrast-Enhanced Exams?
Who Should Be Premediciated for Contrast-Enhanced Exams? Jeffrey C. Weinreb, MD,FACR Yale University School of Medicine jeffrey.weinreb@yale.edu Types of Intravenous Contrast Media Iodinated Contrast Agents
More information09/17/2018. Standing Order for Influenza Vaccine for SKIIP Participants
Purpose: To reduce the morbidity and mortality of influenza by vaccinating those children and adolescents who meet the criteria established by the Centers for Disease Control and Prevention s (CDC) Advisory
More informationANAPHYLAXIS. Following Vaccination of Adults. A Severe Adverse Event
ANAPHYLAXIS Following Vaccination of Adults A Severe Adverse Event Developed for the Grampians Infection Control Group () Version 3.0:2018 Target audience This information package is for nurse immunisers
More informationLEMTRADA REMS Education Program for Healthcare Facilities
For Healthcare Facilities LEMTRADA REMS Education Program for Healthcare Facilities This Educational Piece Includes Information About: The LEMTRADA REMS Program requirements to implement in your healthcare
More informationMedical Directive. Activation Date: July 1, 2011 Review due by: December 1, Medical Director: Date Reviewed: December 1, 2016
Medical Directive Title: Emergency Treatment of Anaphylaxis / Severe Allergic Reactions to Allergy Injections or Immunizations Assigned Number: 007 Activation Date: July 1, 2011 Review due by: December
More informationGuidelines for the administration of Rituximab
the administration of 1. Introduction Administration of the anti-cd20 monoclonal antibody is associated with severe hypersensitivity reactions, potentially life threatening cytokine release syndrome, and
More informationRegimen Reference Order MYEL daratumumab + bortezomib + dexamethasone (DVd) ARIA: MYEL - [DVd]
Updated: January 8, 2019 Regimen Reference Order MYEL daratumumab + bortezomib + dexamethasone (DVd) ARIA: MYEL - [DVd] Planned Course: Indication for Use: CVAD: At Provider s Discretion Proceed with treatment
More informationManagement of Hypersensitivity Reactions: A Nursing Perspective
Management of Hypersensitivity Reactions: A Nursing Perspective Review Article [1] February 01, 2009 By Pamela Hallquist Viale, RN, MS, CS [2] Oncology clinicians administer monoclonal antibodies (MoAbs)
More informationPALS Pulseless Arrest Algorithm.
PALS Pulseless Arrest Algorithm. Kleinman M E et al. Circulation 2010;122:S876-S908 PALS Bradycardia Algorithm. Kleinman M E et al. Circulation 2010;122:S876-S908 PALS Tachycardia Algorithm. Kleinman M
More informationAllergic Reactions and Anaphylaxis. William Mapes, NRP, I/C Chief, Brandon Area Rescue Squad Brandon, VT
Allergic Reactions and Anaphylaxis William Mapes, NRP, I/C Chief, Brandon Area Rescue Squad Brandon, VT Allergy to Anaphylaxis Defined as a histamine-mediated spectrum of physiologic events that include:
More informationMABEES. MFR & Basic EMT Epinephrine Study
MABEES MFR & Basic EMT Epinephrine Study Acknowledgements This program is a State of Michigan approved special study designed by members of the Oakland County Medical Control Authority American CME developed
More informationDelaware Health and Social Services Division of Public Health Standing Orders July 22, 2017 June 30, 2018
Delaware Health and Social Services Division of Public Health Standing Orders July 22, 2017 June 30, 2018 MANAGEMENT OF MEDICAL EMERGENCIES Emergency situations involving DPH clients and/or DPH staff may
More informationChapter 21. Objectives. Objectives 01/09/2013. Anaphylactic Reactions
Chapter 21 s Prehospital Emergency Care, Ninth Edition Joseph J. Mistovich Keith J. Karren Copyright 2010 by Pearson Education, Inc. All rights reserved. Objectives 1. Define key terms introduced in this
More informationOCMCA Education Task Force. Practical Skill Guide
OCMCA Education Task Force Practical Skill Guide MFR & Basic MFR/EMT Epinephrine Study (MABEES) Practical Component In-service training: MFR & Basic MFR/EMT Epinephrine Study (MABEES) Purpose: Every licensed
More informationGUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION
GUIDELINES FOR WEIGHT-BASED DOSING AND INFUSION Includes Example dose calculation wheel Preparation and administration information for healthcare professionals Please see enclosed full Prescribing Information,
More informationObjectives. 3HP and Flu Syndrome What is the Underlying Mechanism? Case #1 3/23/2016. Christina T. Fiske, MD MPH March 30, 2016
Objectives 3HP and Flu Syndrome What is the Underlying Mechanism? Christina T. Fiske, MD MPH March 30, 2016 Illustrate the side effect of 3HP flu like syndrome after its initiation to raise awareness in
More informationIg Therapy: One Size Does Not Fit All
Ig Therapy: One Size Does Not Fit All Carla Duff, CPNP, MSN, IgCN Advanced Registered Nurse Practitioner University of South Florida Division of Allergy, Immunology, and Rheumatology 1 Objectives Understand
More informationINFUSING. ORENCIA (abatacept) IV INDICATION/USAGE. Your go-to guide for preparing and administering an ORENCIA intravenous (IV) infusion
INFUSING ORENCIA (abatacept) IV Your go-to guide for preparing and administering an ORENCIA intravenous (IV) infusion INDICATION/USAGE Adult Rheumatoid Arthritis (RA): ORENCIA is indicated for reducing
More informationBC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab
BC Cancer Protocol Summary for Treatment of Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia with Fludarabine and rituximab Protocol Code Tumour Group Contact Physicians LYCLLFLUDR Lymphoma Dr.
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE TITLE: ISSUED FOR: PARENTERAL NUTRITION AND INTRAVENOUS FAT EMULSION (ADULT AND PEDIATRICS) Nursing DATE: REVIEWED: PAGES: RESPONSIBILITY: RN, LPN II 12/80
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Pharmacy Services PARENT DOCUMENT TITLE, TYPE AND NUMBER Not applicable DOCUMENT # INITIAL EFFECTIVE DATE REVISION
More informationAnaphylaxis Emergency Plan (individual)
Appendix D Anaphylaxis Emergency Plan (individual) Recommendation In schools and other child care settings, each child at risk of anaphylaxis should have an Anaphylaxis Emergency Plan. (See following page.)
More informationIntroduction: Severe adverse reactions:
Immunotherapy and Anaphylaxis: Risks, Prevention, Recognition and Treatment by Frederick M. Schaffer, M.D. Associate Professor, The Medical University of South Carolina Introduction: Immunotherapy (IT)
More informationALLERGIC EMERGENCIES 5/8/2015. Objectives for Pharmacists. Patient Case. Objectives for Technicians. Definition of Anaphylaxis.
ALLERGIC EMERGENCIES Kristina Dawson, PharmD, BCPS Objectives for Pharmacists Describe the immunologic pathways to cause an allergic response Identify the most common triggers to cause Choose the appropriate
More informationIt is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?
PATIENT & CAREGIVER EDUCATION Ondansetron Brand Names: US Zofran; Zofran ODT [DSC]; Zuplenz Brand Names: Canada Ondissolve ODF; Zofran ODT What is this drug used for? It is used to treat or prevent upset
More information